Evidence of long-lasting humoral and cellular immunity against SARS-CoV-2 even in elderly COVID-19 convalescents showing a mild to moderate disease progression

Bastian Fischer, Christopher Lindenkamp, Christoph Lichtenberg, Ingvild Birschmann, Cornelius Knabbe, Doris Hendig
doi: https://doi.org/10.1101/2021.02.23.21251891

Article usage

Article usage: February 2021 to January 2025

AbstractFullPdf
Feb 202110270229
Mar 20212791167
Apr 2021192833
May 20211501531
Jun 20211271125
Jul 2021264520
Aug 2021831523
Sep 2021122419
Oct 202168238
Nov 202170425
Dec 20213679
Jan 20223876
Feb 20222342
Mar 20222836
Apr 20222106
May 202222012
Jun 202221065
Jul 202213055
Aug 20221424
Sep 202235312
Oct 20222605
Nov 20221823
Dec 20222015
Jan 20232217
Feb 20231326
Mar 20231312
Apr 20233016
May 20231118
Jun 20231253
Jul 20231053
Aug 202318157
Sep 202310106
Oct 20231235
Nov 20231192
Dec 20231401
Jan 2024744
Feb 20241842
Mar 2024782
Apr 2024361
May 20241618
Jun 20241324
Jul 20241008
Aug 2024817
Sep 20242247
Oct 2024751
Nov 20241325
Dec 202418510
Jan 2025727
Back to top
Posted February 24, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Evidence of long-lasting humoral and cellular immunity against SARS-CoV-2 even in elderly COVID-19 convalescents showing a mild to moderate disease progression
Bastian Fischer, Christopher Lindenkamp, Christoph Lichtenberg, Ingvild Birschmann, Cornelius Knabbe, Doris Hendig
medRxiv 2021.02.23.21251891; doi: https://doi.org/10.1101/2021.02.23.21251891
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area